tiprankstipranks
EVE Health Group Limited (AU:EVE)
ASX:EVE
Australian Market

EVE Health Group Limited (EVE) Income Statement

0 Followers

EVE Health Group Limited Income Statement

Last quarter (Q4 2022), EVE Health Group Limited's total revenue was AU$―, a decrease of ― from previous quarter. In Q4, EVE Health Group Limited's net income was AU$―. See EVE Health Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Jun 22Jun 21Jun 20Jun 19
Total Revenue
-AU$ 2.39MAU$ 2.80MAU$ 2.31MAU$ 1.60M
Cost of Revenue
-AU$ 1.41MAU$ 1.16MAU$ 1.31MAU$ 1.32M
Gross Profit
-AU$ 976.07KAU$ 1.64MAU$ 999.75KAU$ 277.36K
Operating Expense
-AU$ 5.30MAU$ 5.14MAU$ 3.62MAU$ 2.02M
Operating Income
-AU$ -4.32MAU$ -3.51MAU$ -2.62MAU$ -1.74M
Net Non Operating Interest Income Expense
-AU$ -6.91KAU$ -22.01KAU$ -7.33KAU$ -86.68K
Other Income Expense
-AU$ -1.05MAU$ -101.81KAU$ -380.85KAU$ -809.66K
Pretax Income
-AU$ -5.37MAU$ -3.63MAU$ -3.00MAU$ -2.64M
Tax Provision
-AU$ 0.00AU$ 0.00AU$ -604.02KAU$ 0.00
Earnings From Equity Interest Net Of Tax
-----
Net Income Common Stockholders
-AU$ -5.37MAU$ -3.63MAU$ -2.40MAU$ -2.64M
Basic EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01
Diluted EPS
-AU$ >-0.01AU$ >-0.01AU$ >-0.01AU$ >-0.01
Basic Average Shares
-AU$ 4.01BAU$ 4.59BAU$ 3.74BAU$ 2.30B
Diluted Average Shares
-AU$ 4.01BAU$ 4.59BAU$ 3.74BAU$ 2.30B
Dividend Per Share
-----
Total Operating Income As Reported
-----
Reported Normalized Basic E P S
-----
Reported Normalized Diluted E P S
-----
Rent Expense Supplemental
-----
Total Expenses
-----
Net Income From Continuing And Discontinued Operation
-AU$ -5.37MAU$ -3.63MAU$ -2.40MAU$ -2.64M
Normalized Income
-AU$ -4.54MAU$ -3.63MAU$ -2.40MAU$ -2.64M
Interest Expense
-AU$ 14.11KAU$ 48.35KAU$ 7.33KAU$ 86.68K
EBIT
-AU$ -5.36MAU$ -3.58MAU$ -3.00MAU$ -2.55M
EBITDA
-AU$ -5.03MAU$ -3.26MAU$ -2.72MAU$ -2.39M
Currency in AUD

EVE Health Group Limited Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis